Plasma CRP has been proposed as a sensitive serological surrogate parameter for elevated levels of pro-inflammatory cytokines stimulating angiogenesis, tumor proliferation, and growth and represents an easily measurable, blood-based biomarker routinely analyzed before the initiation of treatment [11,12]. The gene discussed is CRP; the disease is neoplasm.